Device/drug export measure should be added to rescissions bill -- Gingrich.
This article was originally published in The Gray Sheet
Executive Summary
DEVICE/DRUG EXPORT BILL SHOULD BE PASSED AND PUT IN RESCISSION BILL within the next two weeks, House Speaker Gingrich (R-Ga.) suggested during a June 15 conference on medical innovation sponsored by the Washington, D.C.-based Progress & Freedom Foundation. "If any sophisticated country in the world approves a particular product, you should be able to make it in the U.S. for export purposes," Gingrich remarked.